On March 1, 2023 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following conferences (Press release, Iovance Biotherapeutics, MAR 1, 2023, View Source [SID1234627946]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Cell Therapy Virtual Conference
Fireside Chat: February 28, 2023, on-demand
Virtual
Cowen Health Care Conference
Fireside Chat: March 7, 2023 at 2:50 p.m. ET
Boston, MA
Oppenheimer 33rd Annual Healthcare Conference
Presentation: March 14, 2023 at 2:00 p.m. ET
Virtual
Barclays 2023 Global Healthcare Conference
Fireside Chat: March 15, 2023 at 1:35 p.m. ET
Miami, FL
The live and archived webcasts will be available at View Source